American Cancer Society revises guidelines, urges routine PSA screening for prostate cancer

Adobe

In major shift, ACS recommends biennial blood tests for average-risk men ages 50-69

In a major change to screening guidelines, the American Cancer Society recommended on Thursday that American men between ages 50 and 69 at an average risk of prostate cancer should test their prostate-specific antigen (PSA) blood levels every two years.

The prior guidelines, released in 2010, left testing for average-risk men to their discretion, after assessing cancer risk with a physician.

PSA screening for prostate cancer reduces disease-specific deaths, new review shows

Similarly, PSA testing recommendations were strengthened for high risk groups — Black men and men with a strong family history of prostate cancer. They are now encouraged to get PSA-based screening yearly starting at 45. Black men in particular disproportionately die from prostate cancer, and the guideline authors said they hope that increased surveillance will reduce the number of Black patients presenting with cancers at advanced stages.